drugset / Trial / NCT00210548

A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia

NCT00210548

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness and safety of 3 doses of paliperidone palmitate in treating subjects with schizophrenia.

Timeline

Start
2005-04
Primary completion
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject paliperidone palmitate Unknown 50 mg Intramuscular
Subject paliperidone palmitate Unknown 100 mg Intramuscular
Subject paliperidone palmitate Unknown 150 mg Intramuscular

Indications